Frederic Scheer

About Frederic Scheer

I believe technology should save lives—and shape a more sustainable future.As CEO and Co-Founder of ALERCELL, I lead an AI-powered molecular diagnostics company transforming cancer detection through precision oncology. Our mission is clear: deliver faster, more accurate, and earlier diagnosis of leukemia and NSCLC to improve outcomes and save lives globally.With over 30 years of experience at the intersection of biotech, sustainability, and innovation, I’ve founded and led category-defining companies across healthcare, materials science, energy, and finance. At Cereplast, I was among the early pioneers in bioplastics—raising $150M+, securing 17 patents, building two plants, and leading the company to a successful NASDAQ listing.My career reflects a consistent pattern: building ventures that disrupt, innovate, and scale—with impact. Whether in molecular diagnostics, AI healthcare applications, renewable energy, or sustainable materials, I’ve combined scientific rigor with entrepreneurial vision.Select highlights-Built ALERCELL into a global leader in AI-based leukemia and lung cancer diagnostics-Completed advanced studies at Harvard Medical School (Genetics, Precision Oncology) and MIT (AI in Healthcare)-Founded and scaled Cereplast, a trailblazer in bioplastics and biodegradable materials-Co-founded multiple ventures across energy, media, logistics, and finance-Chair of The Frederic & Jocelyne Scheer Foundation, delivering food security and economic empowerment in Africa.I am driven by purpose, guided by innovation, and grounded in execution. If you’re exploring collaboration in diagnostics, AI, biotech, or sustainability—I’d welcome the opportunity to connect.

Experience

1. Chief Executive Officer

   Alercell

   Jun 2020 — Present

   Montana company is a molecular diagnostics company pioneering novel therapeutics to discover, develop, and commercialize solutions for clinical unmet needs, with a primary focus in Oncology in-vitro Diagnostic Testing and Neuroscience. The company was founded with the aim of providing more accurate and timely diagnostic tools for cancer patients worldwide. Alercell\'s mission is to make a difference in the fight against cancer by providing innovative and accurate diagnostic solutions that improve patient outcomes.

Education

• University of Paris I: Panthéon-Sorbonne

  Doctorat

  1978 — 1983

• MIT Sloan School of Management

  Artificial Intelligence

• Sciences Po

  MBA, Public Service

  1974 — 1977

• HMX – Harvard Medical School

  Certificate of Achievement, Genetics - Genetic Testing and Sequencing Technologies

• Paris-Pantheon-Assas University

  Doctorat, LAW

  1973 — 1978

• HMX – Harvard Medical School

  Cancer Genomics and Precision Oncology

• Sciences Po

  Master of Business Administration - MBA, Public Administration and Social Service Professions